NCT05282459 2026-04-17Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 MutationStanford UniversityPhase 1/2 Completed17 enrolled 12 charts
NCT00658814 2026-03-31Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 2 Active not recruiting133 enrolled 10 charts